Project Details
Description
A Phase III, Randomized, Placebo-controlled, Double-blind Study to Assess the Efficacy and Safety of Once-daily Orally Administered ZD4054 10 mg in Non-metastatic Hormone-resistant Prostate Cancer Patients
| Status | Finished |
|---|---|
| Effective start/end date | 7/1/09 → 12/31/11 |
Funding
- AstraZeneca
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.